All News #Library
Biotech
AACR 2026 Will Showcase Novel NK Engager Data
14 Apr 2026 //
PHARMIWEB
Expert Consensus Supports Use of Pepaxti in Myeloma
11 Nov 2025 //
PHARMIWEB
Oncopeptides Collaborates With Top Universities On NK Cell
04 Nov 2025 //
PHARMIWEB
Issue and re-purchase of class C shares for shareholder program
27 Feb 2025 //
PHARMAWEB
Pepaxti Real-World Data Published in Eur J Haematology
25 Feb 2025 //
PHARMAWEB
Oncopeptides’ Pepaxti formally approved for full reimburse in Italy
28 Jan 2025 //
PHARMAWEB
Oncopeptides Expands WODA Partnership To Africa And Eurasia
04 Sep 2024 //
GLOBENEWSWIRE
Oncopeptides, Vector partner to distribute Oncopeptides’ Pepaxti in MENA
30 Mar 2024 //
PHARMABIZ
FDA formally pulls Oncopeptides` cancer drug after prolonged back-and-forth
23 Feb 2024 //
ENDPTS
CDER challenges Oncopeptides’ appeal over Pepaxto withdrawal
13 Sep 2023 //
ENDPTS
FDA publishes Oncopeptides’ withdrawal appeal for Swedish biotech’s Pepaxto
25 Aug 2023 //
ENDPTS
Oncopeptides challenges FDA`s withdrawal of cancer drug`s accelerated approval
11 Aug 2023 //
ENDPTS
Oncopeptides says Swedish authorities ended probe into CSO Jakob Lindberg
30 May 2023 //
ENDPTS
Oncopeptides exec is arrested for allegedly passing insider information
08 Mar 2023 //
ENDPTS
Oncopeptides Chief Financial Officer Holger Lembrer takes office today
18 Jan 2023 //
PR NEWSWIRE
The C-suite shuffle: Oncopeptides, Zymeworks replace execs to start 2023
05 Jan 2023 //
ENDPTS

Market Place
Sourcing Support